stockrow
Monday 9 November 2026
Export LTGO’s income statement to Excel — free account
Latigo Biotherapeutics Inc
LTGO
13.24
0.64
+5.08%
Follow LTGO
Alert me
Latigo Biotherapeutics Inc (LTGO) P/E ratio
P/E ratio, daily
Annual newest first
| Period | P/E ratio | Change |
|---|
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| IVA Inventiva S.A. Sponsored ADR compare | n/m |
| GLUE Monte Rosa Therapeutics, Inc. compare | n/m |
| ANRO Alto Neuroscience, Inc. compare | n/m |
| ORIC Oric Pharmaceuticals, Inc. compare | n/m |
| SNDX Syndax Pharmaceuticals, Inc. compare | n/m |
| RIGL Rigel Pharmaceuticals, Inc. compare | 2.4× |
| PHAR Pharming Group N.V. Sponsored ADR compare | 34.1× |
| CTY City Therapeutics, Inc compare | — |
| LTGO Latigo Biotherapeutics Inc | — |
| Biotechnology industry median | 10.6× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)